Part 1. Formulations

Our goals in this endeavor are to improve understanding among urologists relative to Intracavernosal Injection (ICI) for erectile dysfunction (ED), and to try and standardize our delivery of care relative to treatment and education.

A number of providers prescribe items like Trimix, with no thought given to the particular formulation or implications. Many older physicians will use "stampers" with rarely used formulations, many of which may be far below the more commonly used recipes. Concepts like thresholds for batch testing and even timelines for stability based on refrigeration/frozen storage are poorly understood by many prescribers.

We hope that input from compounding pharmacists can help urologists be more efficient with prescribing ICI for patients. Your response by October 17, 2020, is greatly appreciated.

Question Title

* 1. What is your most commonly dispensed medication for ICI?

Question Title

* 2. When compounding Trimix, what is your most commonly used concentration of alprostadil per mL?

Question Title

* 3. When compounding Trimix, do you commonly vary from using a papaverine concentration of 30 mg/mL?

Question Title

* 4. When compounding Trimix, what is your most commonly used concentration of phentolamine?

Question Title

* 5. How often do your prescribers defer to you for recommending dosing relative to ICI?

Question Title

* 6. Do you dispense single-doses of ICI-medication for test injection?

Question Title

* 7. How often do have to go back to the provider to request a change in formulation?

Question Title

* 8. How often do customers switch between types of ICI (e.g., from Trimix to Bimix, from single agent therapy to multiple-agent medication)?

0 of 21 answered
 

T